OUIMA JUSTIN DIEUDONNE ZIBA

Dr. OUIMA JUSTIN DIEUDONNE ZIBA

orcid

Research Focus & Metrics

Academic Career Length

6Years (2021-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
21 April 2024 in Urology
Verified
Journal Article
Closed access
OZOUIMA JUSTIN DIEUDONNE ZIBA
OUIMA JUSTIN DIEUDONNE ZIBA
SNSaleh NEDJIM
Saleh NEDJIM
AKAnteneh Tadesse Kifle
Anteneh Tadesse Kifle
KGKaleab Habtemichael Gebreselassie
Kaleab Habtemichael Gebreselassie
BGBotcho Gnimdou
Botcho Gnimdou
KAKabore Fasnewende Aristide
Kabore Fasnewende Aristide

24 June 2021 in Case Reports in Hepatology
Verified
Journal Article
Open access
PDF file
HAHakima Abid
Hakima Abid
MFMouna Figuigui
Mouna Figuigui
SISidi Adil Ibrahimi
Sidi Adil Ibrahimi
MAMohamed El Abkari
Mohamed El Abkari
MMMohamed Mzyiene
Mohamed Mzyiene
LCLaila Chbani
Laila Chbani
Bacillus Calmette and Guérin (BCG), widely used as a vaccination to prevent tuberculosis, is also used as immunotherapy, by intrabladder instillation, to treat superficial bladder cancers and prevent recurrence. Complications following instillation of BCG are most often localized reactions, such as cystitis or hematuria. They can more rarely be generalized and potentially severe such as hepatitis, pneumopathies, aortitis, and localization to hematopoietic tissue. We have reported the observation of a 47-year-old patient followed up for a bladder tumor operated for transurethral resection of the bladder, then having benefited from an instillation of BCG therapy complicated by occurrence a week later of an acute hepatitis. The diagnostic time was 2 days, and the outcome was favorable with corticosteroid therapy.

6 February 2025 in The Prostate
Verified
Journal Article
Closed access
OZOUIMA JUSTIN DIEUDONNE ZIBA
OUIMA JUSTIN DIEUDONNE ZIBA
KGKaleab Habtemichael Gebreselassie
Kaleab Habtemichael Gebreselassie
TMTaofiq Olayinka Mohammed
Taofiq Olayinka Mohammed
AKAbdullahi Khalid
Abdullahi Khalid
SNSaleh NEDJIM
Saleh NEDJIM
KAKabore Fasnewende Aristide
Kabore Fasnewende Aristide

25 October 2024 in The French Journal of Urology
Verified
Journal Article
Closed access
MKMoussa Kabore
Moussa Kabore
OZOUIMA JUSTIN DIEUDONNE ZIBA
OUIMA JUSTIN DIEUDONNE ZIBA
CYClotaire Alexis Marie Kiemdiba Donega Yameogo
Clotaire Alexis Marie Kiemdiba Donega Yameogo
AOAdama Ouattara
Adama Ouattara
BKBrahima Kirakoya
Brahima Kirakoya
FKFasnéwindé Aristide Kabore
Fasnéwindé Aristide Kabore


5 August 2021 in Urology & Nephrology Open Access Journal
Verified
Journal Article
Open access
PDF file
MMMzyiene X Mzyiene Mohammed
Mzyiene X Mzyiene Mohammed
OZOUIMA JUSTIN DIEUDONNE ZIBA
OUIMA JUSTIN DIEUDONNE ZIBA
MAMustapha Ahsaini
Mustapha Ahsaini
MSMellas Soufiane
Mellas Soufiane
MTMohammed Fadl Tazi
Mohammed Fadl Tazi
MFMoulay Hassan Farih
Moulay Hassan Farih
Introduction: Prostate biopsy (PB) is a routine procedure performed by urologists in cases of suspected prostate cancer, any abnormality in the prostate-specific antigen (PSA) assay, and/or perceived by the digital rectal exam. Although this is a safe and rapid procedure, it is not without potentially serious complications, including infectious complications ranging from asymptomatic bacteriuria to acute prostatitis and even septic shock. Materials and methods: This work reports the experience of the urology department of the Hassan II University Hospital of Fez in the study of post-biopsy prostatitis through the analysis of a retrospective series of 538 cases during the period January 2014 - December 2018. Results: We report 11 cases of acute post-biopsy prostatitis diagnosed in the urology department of the Hassan II University Hospital in Fez. The bacteria most frequently involved in post-biopsy infections are gram-negative bacteria (Escherichia coli, Klebsiella pneumonia, Acinetobacter baumannii) although gram-positive cocci (Enterococcus faecalis and Staphylococcus saprophyticus) can also be responsible. Anaerobic bacteria are rarely found. The treatment of these post-biopsy infections is based on prolonged antibiotic therapy (3 to 6 weeks) using third-generation cephalosporins (Ceftriaxone). In our series, no death, septic shock, or prostatic abscess was found. The evolution was towards a good improvement under antibiotic treatment with discharge at home after 48 hours of apyrexia. Conclusion: The study of infectious complications secondary to prostate biopsy makes it possible to determine the most appropriate empirical (therapeutic and prophylactic) regimens to minimize the risks. Because of the prevalence of infection by multi-resistant bacteria, particularly to quinolones, the biopsy must be performed following the rules of antibiotic prophylaxis.